# Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

> **NCT00301002** · PHASE2 · COMPLETED · sponsor: **The Guenther Dermatology Research Centre** · enrollment: 15 (—)

## Conditions studied

- Psoriasis
- Palmoplantaris Pustulosis
- Pustular Psoriasis of Palms and Soles
- Pustulosis Palmaris et Plantaris
- Pustulosis of Palms and Soles

## Interventions

- **DRUG:** Alefacept

## Key facts

- **NCT ID:** NCT00301002
- **Lead sponsor:** The Guenther Dermatology Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 15 (—)
- **Last updated:** 2006-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301002, "Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00301002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*